Does Rallies show 13F holders for CODX?

Yes. Rallies tracks hedge fund and 13F ownership data for CODX, including fund names, share counts, latest tracked quarter, and position changes when available.

Is CODX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CODX. It does not provide personalized investment advice.

CODX (Co-Diagnostics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Co-Diagnostics, Inc. Common Stock (CODX) is a publicly traded Healthcare sector company. As of May 21, 2026, CODX trades at $2.45 with a market cap of $4.94M and a P/E ratio of -0.06. CODX moved +21.32% today. Year to date, CODX is -58.36%; over the trailing twelve months it is -71.03%. Its 52-week range spans $1.26 to $46.50. Rallies surfaces CODX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CODX stock?

Hedge funds tracked by Rallies that own CODX include Renaissance Technologies, Citadel Advisors, and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Co-Diagnostics, Inc. Common Stock.

CODX Key Metrics

Key financial metrics for CODX
Metric	Value
Price	$2.45
Market Cap	$4.94M
P/E Ratio	-0.06
EPS	$-39.08
Dividend Yield	0.00%
52-Week High	$46.50
52-Week Low	$1.26
Volume	77.57K
Avg Volume	0
Revenue (TTM)	$718.17K
Net Income	$-48.50M
Gross Margin	45.06%

Top Hedge Funds Holding CODX

Renaissance Technologies holds 555.62K shares of CODX, changed -2.13% as of Dec 31, 2024.
Citadel Advisors holds 16.47K shares of CODX, changed -35.23% as of Dec 31, 2024.
Two Sigma holds 16.46K shares of CODX, changed -6.46% as of Dec 31, 2024.

Latest CODX News

CoMira Finalizes Lease for Manufacturing Plant in Saudi Arabia’s Sudair City — May 11, 2026
Co-Diagnostics JV CoMira Secures 14,400-Sq Ft Saudi Manufacturing Lease — May 8, 2026
Co-Diagnostics Joins April Trade Mission in Switzerland and Germany with Roche, UBS — Apr 9, 2026
Co-Diagnostics Expands Distribution to Four Countries, Accessing $13B Market — Mar 20, 2026

CODX Analyst Consensus

CODX analyst coverage data. Average price target: $0.00.

Common questions about CODX

Who owns CODX stock?: Hedge funds tracked by Rallies that own CODX include Renaissance Technologies, Citadel Advisors, and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Co-Diagnostics, Inc. Common Stock.
Does Rallies show 13F holders for CODX?: Yes. Rallies tracks hedge fund and 13F ownership data for CODX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CODX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CODX. It does not provide personalized investment advice.